FOI release

Inquiry regarding Public Assessment Reports for Ibuprofen 100mg/5mL Oral Suspension

Case reference FOI2026/00669

Received 22 June 2026

Published 12 August 2026

Request

Could you please confirm whether PAR’s are available for these products? If any of these PARs is not available, could you please advise under which authorisation route the product was approved, and what the reference product is? • PL 00142/0977, for which Accord is the MA holder • PL 15513/0157, for which McNeil is the MA holder • PL 20416/0535, for which Crescent Pharma Limited is the MA holder • PL 46302/0011, for which Mylan is the MA holder • PL 16028/0034, for which Galpharm is the MA holder

Response

See attached

Documents

• FOI2026_00669 (redacted).pdf (897.4 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.